|
🐜
|
Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.
8 auth.
J. Narváez,
P. Juarez-López,
J. Lluch,
J. Narváez,
R. Palmero,
X. G. Muro,
...
J. Nolla,
E. Domingo-Domènech
|
6 |
2018 |
6
🐜
|
|
🐜
|
Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression.
7 auth.
J. Narváez,
J. Lluch,
M. Molina-Molina,
V. Vicens-Zygmunt,
P. Luburich,
Marcos Anibal Yañez,
...
J. Nolla
|
4 |
2020 |
4
🐜
|
|
🐬
|
Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
J. Narváez,
J. Pirola,
J. Lluch,
P. Juárez,
J. Nolla,
A. Valenzuela
|
4 |
2019 |
4
🐬
|
|
🐬
|
Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series
J. Narváez,
J. Lluch,
J. J. Alegre Sancho,
M. Molina-Molina,
J. Nolla,
I. Castellví
|
4 |
2018 |
4
🐬
|
|
🐜
|
Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report.
8 auth.
P. Lluch,
A. Urruticoechea,
J. Lluch,
M. Moll,
M. Matos,
J. Benet,
...
L. Ene,
J. Cañete
|
4 |
2012 |
4
🐜
|
|
🐜
|
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
23 auth.
J. Tandaipan,
A. Guillén-Del-Castillo,
C. Simeón-Aznar,
P. Carreira,
C. de la Puente,
J. Nárvaez,
J. Lluch,
M. Rubio-Rivas,
J. Alegre-Sancho,
G. Bonilla,
...
C. Moriano,
I. Casafont-Solé,
R. García-Vicuña,
V. Ortiz-Santamaria,
E. Riera,
B. Atienza-Mateo,
R. Blanco,
C. Galisteo,
J. González-Martín,
J. Pego-Reigosa,
A. Pros,
S. Heredia,
I. Castellví
|
3 |
2023 |
3
🐜
|
|
🦁
|
Breast involvement in granulomatosis with polyangiitis.
J. Lluch,
Laia Montserrat Pérez-Tapia,
María Taco-Sánchez,
J. Narváez
|
3 |
2019 |
3
🦁
|
